Moderna - Marlborough Biomanufacturing Center
Courtesy of Moderna.
Moderna is investing $322 million to create a state-of-the-art biomanufacturing center in Marlborough, Mass. Offering leading-edge environments for the production of innovative therapies and vaccines, the state-of-the-art facility will also include a cleanroom, labs, offices, and warehouse areas. The project involves the renovation of a two-story, 140,000-sf building that was purchased in spring of 2023 from Oxford Properties. Sited on 24 acres, the existing structure will be expanded to provide an additional 60,000 sf of space.
Headquartered in nearby Cambridge, Moderna will hire at least 200 full-time employees to perform engineering and technical operations at the cGMP plant. Occupancy is expected in September of 2024.
